What exactly do you mean? I can’t see one area where they have not met or exceeded their targets?
If you are talking about the share price then perhaps you should look at it as a quality company on sale. I think it’s a screaming buy.
I don’t believe any of the “the market hasn’t noticed this one yet” talk. The fact the share price is low has to do with poor capital management. Cannacord filled the register with hot money.
- Forums
- ASX - By Stock
- PYG
- Ann: Record FY21 results deliver positive EBITDA
Ann: Record FY21 results deliver positive EBITDA, page-70
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)